美国 · SEC FORM 4
Inotiv, Inc.
NOTVQ · — · CIK 0000720154 · Healthcare
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
19 同一窗口内观察到的 Form 4 交易行
0 sales · 19 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 6 additional owner(s) remain in Form 4 申报证据.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-12-19 · Landman David.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
FINRA 报告中没有该股票代码的空头余额。
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2024-12-19 | Landman David | 买入 (P) | Common Stock | 23,529 | USD 4.25 | USD 99,998 | SEC 申报 ↗ |
| 2024-12-10 | Beattie John Gregory | 买入 (P) | Common Stock | 30,000 | USD 4.75 | USD 142,500 | SEC 申报 ↗ |
| 2024-12-10 | Brown Nigel | 买入 (P) | Common Stock | 7,500 | USD 4.26 | USD 31,950 | SEC 申报 ↗ |
| 2024-12-06 | Landman David | 买入 (P) | Common Stock | 100,000 | USD 4.14 | USD 414,000 | SEC 申报 ↗ |
| 2024-12-06 | Harrington Michael J | 买入 (P) | Common Stock | 10,000 | USD 3.98 | USD 39,800 | SEC 申报 ↗ |
| 2023-12-14 | Garrett Michael | 买入 (P) | Common Stock | 5,000 | USD 2.83 | USD 14,150 | SEC 申报 ↗ |
| 2023-12-14 | Beattie John Gregory | 买入 (P) | Common Stock | 47,966 | USD 3.12 | USD 149,654 | SEC 申报 ↗ |
| 2023-03-14 | Sagartz John E | 买入 (P) | Common Stock | 5,100 | USD 4.91 | USD 25,041 | SEC 申报 ↗ |
| 2023-02-22 | Beattie John Gregory | 买入 (P) | Common Stock | 5,000 | USD 6.99 | USD 34,950 | SEC 申报 ↗ |
| 2022-09-15 | Garrett Michael | 买入 (P) | Common Stock | 1,000 | USD 23.06 | USD 23,060 | SEC 申报 ↗ |
| 2022-09-09 | Beattie John Gregory | 买入 (P) | Common Stock | 8,900 | USD 22.34 | USD 198,826 | SEC 申报 ↗ |
| 2022-03-15 | Harkness James | 买入 (P) | Common Shares | 38,968 | USD 19.65 | USD 765,584 | SEC 申报 ↗ |
| 2022-02-22 | Downing Philip A | 买入 (P) | Common Shares | 2,000 | USD 23.97 | USD 47,940 | SEC 申报 ↗ |
| 2022-02-18 | Taylor Beth | 买入 (P) | Common Shares | 5,000 | USD 23.07 | USD 115,350 | SEC 申报 ↗ |
| 2022-02-18 | Garrett Michael | 买入 (P) | Common Shares | 1,000 | USD 23.50 | USD 23,500 | SEC 申报 ↗ |
Form 4 申报证据
26 transaction lines in the latest 365-day window; 202 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-19 | Taylor Beth A. | J (J) | Common Stock | 139,616 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-19 | Sagartz John E | J (J) | Common Stock | 729,626 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-19 | Neff R Matthew | J (J) | Common Stock | 151,102 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (25 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-19 | Taylor Beth A. | J (J) | Common Stock | 139,616 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-19 | Sagartz John E | J (J) | Common Stock | 729,626 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-19 | Neff R Matthew | J (J) | Common Stock | 151,102 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-19 | Leasure Robert Jr. | J (J) | Common Stock | 1,361,215 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-19 | Landman David | J (J) | Common Stock | 216,243 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-19 | Harrington Michael J | J (J) | Common Stock | 76,892 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-19 | Hardy Adrian | J (J) | Common Stock | 53,049 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-19 | Freeman Jeffrey Brennan | J (J) | Common Stock | 36,623 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-19 | Coelho Mary Theresa | J (J) | Common Stock | 74,303 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-19 | Castetter Andrea | J (J) | Common Stock | 49,200 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-19 | Brown Nigel | J (J) | Common Stock | 104,929 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-19 | Beattie John Gregory | J (J) | Common Stock | 180,992 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-18 | Taylor Beth A. | 代扣税 (F) | Common Stock | 5,864 | USD 0.02 | USD 117 | SEC 申报 ↗ |
| 2026-06-18 | Sagartz John E | 代扣税 (F) | Common Stock | 6,071 | USD 0.02 | USD 121 | SEC 申报 ↗ |
| 2026-06-18 | Hardy Adrian | 代扣税 (F) | Common Stock | 5,371 | USD 0.02 | USD 107 | SEC 申报 ↗ |
| 2026-06-18 | Freeman Jeffrey Brennan | 代扣税 (F) | Common Stock | 5,855 | USD 0.02 | USD 117 | SEC 申报 ↗ |
| 2026-06-18 | Castetter Andrea | 代扣税 (F) | Common Stock | 5,800 | USD 0.02 | USD 116 | SEC 申报 ↗ |
| 2026-06-18 | Beattie John Gregory | 代扣税 (F) | Common Stock | 5,769 | USD 0.02 | USD 115 | SEC 申报 ↗ |
| 2026-02-17 | Taylor Beth A. | 卖出 (S) | Common Stock | 2,888 | USD 0.29 | USD 838 | SEC 申报 ↗ |
| 2026-02-17 | Sagartz John E | 卖出 (S) | Common Stock | 2,119 | USD 0.29 | USD 615 | SEC 申报 ↗ |
| 2026-02-17 | Leasure Robert Jr. | 卖出 (S) | Common Stock | 16,810 | USD 0.30 | USD 5,043 | SEC 申报 ↗ |
| 2026-02-02 | Leasure Robert Jr. | 卖出 (S) | Common Stock | 113,297 | USD 0.50 | USD 56,648 | SEC 申报 ↗ |
| 2025-12-01 | Neff R Matthew | 卖出 (S) | Common Stock | 2,000 | USD 0.89 | USD 1,780 | SEC 申报 ↗ |
| 2025-11-03 | Neff R Matthew | 卖出 (S) | Common Stock | 2,000 | USD 1.24 | USD 2,480 | SEC 申报 ↗ |
| 2025-10-24 | Neff R Matthew | 期权行权/转换 (M) | Common Stock | 10,000 | USD 1.94 | USD 19,400 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | NOTVQ |
| CIK | 0000720154 |
| 行业 | Healthcare |
| 细分行业 | — Yahoo Finance |
| SEC SIC | 8731 Services-Commercial Physical & Biological Research |
| 交易所 | — |
数据覆盖
| 本地 Form 4 历史 | 202 transaction lines from 2020-01-27 to 2026-07-19 50 P purchase lines · 28 S sale lines · 124 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.